- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04143308
The Effects of Simultaneous Training of Walking and Cognitive Tasks on Cognitive Functions of People With Schizophrenia
The Effects of Simultaneous Training of Walking and Cognitive Tasks on Cognitive Functions of People With Schizophrenia: the Development of Mobile Application System and Effectiveness Analysis
Study Overview
Status
Detailed Description
Background: Schizophrenia is one of the severe mental disorders. In addition to psychiatric symptoms, cognitive impairment is a key clinical feature in this population, which significantly negatively influences their functional performance and independence. While the cognitive remediation therapy demonstrates positive results, it often involves specialized and expensive computerized cognitive training system, which limits its application in clinical setting. More evidence is available to support the benefits of exercise training on cognitive functions of schizophrenia. Combination of exercise and cognitive training is a promising program and can improve cognitive functions of the elderly. However, this combined therapy is still limited to schizophrenia. Simultaneous training of walking and cognitive tasks via auditory mobile application is an innovative program for saving cost, time, and manpower. Further study is needed to develop the simultaneous training program and to examine the effectiveness.
Purposes: To examine the effects of the training program on cognitive functions, fitness, functional performance and quality of life.
Methods: A 3-arm, single-blinded, randomized controlled trial is used to recruit 90 participants and then randomly allocated to the simultaneous training group, the cognitive training group, and the treatment as usual group. The first two training groups receive training for 30-40 minutes, 3 times a week for 12 weeks, as well as a follow-up of 12 weeks. All participants will be assessed at baseline, post-test and follow-up assessment. Primary outcome is cognitive function and secondary outcomes are fitness, functional performance, and quality of life.
Contribution: The study can be used as an evidence-based program to improve cognitive functioning of people with schizophrenia. With the development of mobile App and the use of fitness wearable device, the training program enables people with schizophrenia to walk and practice cognitive training simultaneously in a group format. It will help clinical professionals be able to serve the increasing number of people with severe mental illness with less manpower and specialized equipment. The study is also helpful to better understanding the isolated role of aerobic exercise in the dual-task training, and to apply to other groups, like the elderly or dementia.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Kaohsiung, Taiwan
- Ming-De Chen
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Diagnosis of schizophrenia or schizoaffective disorder by a psychiatric clinician on the basis of the criteria set the Diagnostic and Statistical Manual of Mental Disorders 5th edition, DSM-5, has been more than 1 year.
- Age 20-60 years old.
- Living in daycare center or community-based mental health rehabilitation services or rehabilitation ward.
- Having stable psychiatric conditions (i.e., primary psychiatric medications had not changed for more than two months)
- The MATRICS Consensus Cognitive Battery (MCCB) (Nuechterlein et al., 2008) shows that at least one domain with cognitive impairment (below the value of -1SD).
- Can follow the research process and sign the consent form.
Exclusion Criteria:
- Traumatic brain injury and other neurological diseases, alcohol and substance abuse
- Pregnancy, cardiovascular disease, and unsuitable to exercise training due to physical movement difficulties
- According participants' self-report, having following conditions, including severe heart failure, myocardial infarction, angina pectoris, chronic obstructive pulmonary disease, COPD, poor glycemic control (i.e., dialysis, diabetic neuropathy or retinopathy) and lower extremity arthritis
- Uncontrolled hypertension with SBP> 160 mmHg or DBP> 110 mmHg
- Diagnosis of intellectual disability
- Unconscious or confusion of consciousness
- Participating in other intervention studies
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Simultaneous training of walking and cognitive group
|
Device:
|
|
Active Comparator: Cognitive training group
|
Device:
|
|
Active Comparator: Treatment as usual group
1. Keep treatment as usual group at health care system.
|
Keep treatment as usual
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Cognitive function
Time Frame: Change from baseline outcome measure at 12th week (post-test), and at 24th week (follow-up test)
|
MATRICS Consensus Cognitive Battery: Traditional Chinese Version (MCCB) consists of 10 individually administered tests to measure cognitive performance in the following seven domains:
7.1 Mayer-Salovey-Caruso Emotional Intelligence Test (MSCEIT): Managing Emotions. |
Change from baseline outcome measure at 12th week (post-test), and at 24th week (follow-up test)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Body composition
Time Frame: Change from baseline outcome measure at 12th week (post-test), and at 24th week (follow-up test)
|
Using Body Mass Index (BMI) as the measurement of body composition, which weight and height will be combined to report BMI in kg/m^2.
|
Change from baseline outcome measure at 12th week (post-test), and at 24th week (follow-up test)
|
|
Cardiorespiratory fitness
Time Frame: Change from baseline outcome measure at 12th week (post-test), and at 24th week (follow-up test)
|
Using 6-minute walk test (6MWT) as the measurement, which let the participant walks as far as possible over a total of six minutes on hard and flat floor.
And the researcher will measure the distance that participant walks in 6 minutes.
|
Change from baseline outcome measure at 12th week (post-test), and at 24th week (follow-up test)
|
|
Leg muscular strength and endurance
Time Frame: Change from baseline outcome measure at 12th week (post-test), and at 24th week (follow-up test)
|
Using 30-Second Sit to Stand Test.
The participant will sit in the middle of the chair, and rise to a full standing position, then sit back down again.
Repeat these movements for 30 seconds.
And researcher will count the times.
|
Change from baseline outcome measure at 12th week (post-test), and at 24th week (follow-up test)
|
|
Balance and Agility
Time Frame: Change from baseline outcome measure at 12th week (post-test), and at 24th week (follow-up test)
|
The Timed Up and Go test (TUG).
It measures the time that the participant takes to rise from a chair, walk eight foots, turn around, walk back to the chair, and sit down.
|
Change from baseline outcome measure at 12th week (post-test), and at 24th week (follow-up test)
|
|
Dual-Task Performance Involving Hand Dexterity and Cognitive Tasks
Time Frame: Change from baseline outcome measure at 12th week (post-test), and at 24th week (follow-up test)
|
Dual-Task Performance Involving Hand Dexterity and Cognitive Tasks, this test is combine the Purdue Pegboard Test (PPT; Tiffin & Asher, 1948) and the Serial Sevens Subtraction Test (SSST; Manning, 1982), Purdue Pegboard Test use to measures hand dexterity; Serial Sevens Subtraction Test as a cognitive task for the dual-task condition.
|
Change from baseline outcome measure at 12th week (post-test), and at 24th week (follow-up test)
|
|
Instrumental Activity of Daily Living (IADL)
Time Frame: Change from baseline outcome measure at 12th week (post-test), and at 24th week (follow-up test)
|
Lawton and Brody Instrumental Activity of Daily Living Scale is a self-report survey.
It is used to evaluate the degree of participant's instrumental activities.
There are total 8 descriptions, the scale scores ranges is between 0 to 8. The higher values represent a better outcome.
|
Change from baseline outcome measure at 12th week (post-test), and at 24th week (follow-up test)
|
|
Schizophrenia Quality of Life Scale Revision 4 (SQLS-R4)
Time Frame: Change from baseline outcome measure at 12th week (post-test), and at 24th week (follow-up test)
|
Schizophrenia Quality of Life Scale Revision 4 is a self-report survey.
It is used to evaluate the degree of participant's quality of life.
There are total 33 items, the scale scores statements are rated 1 (never) to 5 (always).
The higher values represent a better outcome.
|
Change from baseline outcome measure at 12th week (post-test), and at 24th week (follow-up test)
|
Collaborators and Investigators
Investigators
- Principal Investigator: Ming-De Chen, Ph.D., Department of Occupational Therapy, College of Health Sciences, Kaohsiung Medical University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- KMUHIRB-SV(I)-20170080
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Quality of Life
-
Ziekenhuis Oost-LimburgRecruitingQuality of Life | Postoperative Quality of Recovery | Health-Related Quality-of-LifeBelgium
-
B. Braun Medical SAUnknownQuality of Life of Colostomized Patient
-
Assiut UniversityUnknownImproving Quality of LifeEgypt
-
Istituto Ortopedico RizzoliUniversity of BolognaCompletedImprove Quality of LifeItaly
-
Children's National Research InstituteCompletedProfessional Quality of LifeUnited States
-
Mattu UniversityCompletedBreif Description: Patients' Quality of Life ofEthiopia
-
Region VästmanlandUnknownHealth Related Quality of Life
-
Ain Shams UniversityCompletedHealth Related Quality of LifeEgypt
-
Institute of Oncology LjubljanaUnknownHealth-related Quality of LifeSlovenia
-
Oslo University HospitalNorwegian Fund for Postgraduate Training in PhysiotherapyCompletedHealth-Related Quality of LifeNorway
Clinical Trials on Simultaneous training of walking and cognitive group
-
Chang Gung UniversityNational Science and Technology CouncilRecruiting
-
University of Missouri, Kansas CitySt. Luke's Hospital, Kansas City, MissouriRecruiting
-
Foundation University IslamabadCompletedBalance | Cognitive FunctionsPakistan
-
IRCCS San RaffaeleActive, not recruitingMild Cognitive Impairment (MCI) | Neurodegenerative Disease | Neurodegenerative Dementia | AMCI - Amnestic Mild Cognitive ImpairmentItaly
-
The Hong Kong Polytechnic UniversityRecruitingSubjective Cognitive DeclineChina
-
Xuanwu Hospital, BeijingNot yet recruiting
-
KU LeuvenWithdrawnIntermittent Claudication | Peripheral Artery Disease
-
NYU Langone HealthIcahn School of Medicine at Mount SinaiCompletedStroke | HemiparesisUnited States
-
University of California, San DiegoAlzheimer's AssociationCompletedMild Cognitive ImpairmentUnited States